New England Journal of Medicine · 1958 · 73 citations · 10 references
MedicineOncologyPharmacologyDrug MetabolismExcretionGastrointestinal OncologyDrug ExcretionGastrointestinal PathophysiologyGastrointestinal PharmacologySerotonergic PharmacologyPharmacology Of Serotonergic AgentsResearch With Human SubjectsSubjects
URINARY excretion of the serotonin metabolite, 5-hydroxyindolacetic acid, was studied both in normal subjects and in patients with a variety of diarrheal states. Three observations led to this investigation. Circulating 5-hydroxytryptamine (serotonin), which is secreted in large amounts by the tumor, causes the cramping abdominal pain and diarrhea of the malignant carcinoid syndrome.1 , 2 Parenterally administered serotonin has a marked effect upon the gut of man and animals.3 , 4 The precursor of serotonin, 5-hydroxytryptophan, produces nausea, abdominal cramps and borborygmi in human beings.5 Subjects and MethodsTwenty-four-hour specimens of urine were collected from 30 normal adults (house-staff and hospital personnel) and from . . .
10
Åke Thorson, Gunnar Biörck, Gunnat Björkman et al. · American Heart Journal · 1954 · 538 citations
Medicine, Cardiology, Oncology +17
HUMORAL EFFECTS OF METASTASISING CARCINOID TUMOURS
P.J.D. Snow, J E Lennard-Jones, G. Curzon et al. · The Lancet · 1955 · 144 citations
Medicine, Cancer Biology, Oncology +10
The effect of 5-hydroxytryptamine on intestinal motor function in man
Thomas R. Hendrix, Michael Atkinson, James Clifton et al. · The American Journal of Medicine · 1957 · 109 citations
Medicine, Pharmacology, Physiology +11